Richard Young
Fortune : 746 344 $ au 31/05/2026
Fortune : 746 344 $ au 31/05/2026
Richard A. Young was the founder of Dewpoint Therapeutics, Inc. (2020), CAMP4 Therapeutics Corp.
(2015) as Independent Director, and Syros Pharmaceuticals, Inc. (2011) as Independent Director.
Current jobs include Director at Precede Biosciences, Inc. (2023), Director at Paratus Sciences Corp.
(2021), Professor-Biology at Massachusetts Institute of Technology (1984), and Member at Whitehead Institute for Biomedical Research (1984).
Former jobs include Independent Director at Enzon Pharmaceuticals, Inc. (2011-2013), Independent Director at Omega Therapeutics, Inc. (2017-2024), and Senior Vice President-Steel Mill Product Sales at Eastern Alloys, Inc. Education includes undergraduate degree from Indiana University and doctorate from Yale University (1975).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 170 010 ( 0,36% ) | 746 344 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Fondateur | 01/01/2015 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | 01/01/1984 |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01/01/1984 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Fondateur | 01/10/2020 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/11/2021 |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Directeur/Membre du Conseil | 01/02/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| OMEA THER | Directeur/Membre du Conseil | 06/12/2024 |
| SYROS PHARMACEUTICALS, INC. | Fondateur | 15/11/2024 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Directeur/Membre du Conseil | 20/11/2013 |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eastern Alloys, Inc.
Eastern Alloys, Inc. Other Metals/MineralsNon-Energy Minerals Manufactures and recycles zinc alloys and products | Non-Energy Minerals |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national